Concomitant Use of Single Antiplatelet Therapy With Edoxaban or Warfarin in Patients With Atrial Fibrillation: Analysis From the ENGAGE AF‐TIMI48 Trial

Publisher： John Wiley & Sons Inc

E-ISSN： 2047-9980|5|2|JAHA.115.002587-JAHA.115.002587

ISSN： 2047-9980

Source： JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol.5, Iss.2, 2016-02, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and Safety of Edoxaban in Elderly Patients With Atrial Fibrillation in the ENGAGE AF–TIMI 48 Trial

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 5, Iss. 5, 2016-05 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety of rivaroxaban compared with warfarin in patients with carotid artery disease and nonvalvular atrial fibrillation: Insights from the ROCKET AF trial

By  

Clinical Cardiology, Vol. 41, Iss. 1, 2018-01 ,pp. : 39-45

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dual Antiplatelet Therapy and Outcomes in Patients With Atrial Fibrillation and Acute Coronary Syndromes Managed Medically Without Revascularization: Insights From the TRILOGY ACS Trial

By  

Clinical Cardiology, Vol. 39, Iss. 9, 2016-09 ,pp. : 497-506

John Wiley & Sons Inc

Access to resources Recommend Favorite

Detection of Atrial Fibrillation by Permanent Pacemakers: Observations from the STOP AF Trial

By Plummer C.J.  

Cardiac Electrophysiology Review, Vol. 7, Iss. 4, 2003-12 ,pp. : 333-340

Springer Publishing Company

Access to resources Recommend Favorite

Increased Heart Rate Is Associated With Higher Mortality in Patients With Atrial Fibrillation (AF): Results From the Outcomes Registry for Better Informed Treatment of AF (ORBIT‐AF)

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 4, Iss. 9, 2015-09 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite